Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetes mellitus in breast cancer survivors: metabolic effects of endocrine therapy
Nisha S. Thomas, Rebecca L. Scalzo, Elizabeth A. Wellberg
Nature Reviews Endocrinology (2023) Vol. 20, Iss. 1, pp. 16-26
Open Access | Times Cited: 10

Showing 10 citing articles:

Multifunctional ZnO@DOX/ICG-LMHP Nanoparticles for Synergistic Multimodal Antitumor Activity
Zhuoyue Li, Jingru Wang, Junwei Liu, et al.
Journal of Functional Biomaterials (2024) Vol. 15, Iss. 2, pp. 35-35
Open Access | Times Cited: 6
Metformin use correlated with lower risk of cardiometabolic diseases and related mortality among US cancer survivors: evidence from a nationally representative cohort study
Yukun Li, Xiaoying Liu, Wenhe Lv, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
CeO2 Nanozyme-Embedded Thermal-Deformative Polymer for Site-Specific Chemotherapy via HIF-1α-P-gp/Lipolysis Axis Reversal
Zhiyuan Tang, Yan Sun, Q. B. Yi, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101023-101023
Open Access
Role of Cardiovascular Health in the Bidirectional Progression Trajectories Between Cardiovascular Disease, Type 2 Diabetes, and Cancer
Yu Peng, Peng Wang, Fubin Liu, et al.
Journal of the American Heart Association (2025)
Open Access
Non-sclerosing (T-cell) and sclerosing (B-cell) lymphocytic lobulitis in diagnostic breast biopsies: Clinical, imaging, and pathologic features
Marie-Hélène Ngo, Geraldine S. Pinkus, Eren D. Yeh, et al.
Human Pathology (2024) Vol. 146, pp. 28-34
Open Access | Times Cited: 2
The research trends and future prospects of nanomaterials in breast cancer
Yue Li, Xiaoqing Li, Aoqun Li, et al.
Cancer Nanotechnology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Cardiovascular and Metabolic Adverse Events of Endocrine Therapies in Women with Breast Cancer: A Disproportionality Analysis of Reports in the FDA Adverse Event Reporting System
Shaimaa Elshafie, Lorenzo Villa‐Zapata, Randall L. Tackett, et al.
Cancer Medicine (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Poorly controlled type II diabetes mellitus significantly enhances postoperative chemoresistance in patients with stage III colon cancer
Ruo‐Yu Guan, Jiawei Wu, Zheng Yuan, et al.
World Journal of Gastroenterology (2024) Vol. 31, Iss. 3
Closed Access | Times Cited: 1
Triple-Negative Breast Cancer EVs Modulate Growth and Migration of Normal Epithelial Lung Cells
Ilaria Leone, Jessie Santoro, Andrea Soricelli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5864-5864
Open Access
Risk of type-2-diabetes after breast cancer treatment: a population-based cohort study in Denmark
Kasper Aalbæk Kjærgaard, Astrid Kousholt, Reimar W. Thomsen, et al.
JNCI Journal of the National Cancer Institute (2024)
Open Access
Page 1

Scroll to top